(OSIS) OSI Systems - Ratings and Ratios
Security Scanners, Patient Monitors, Optoelectronics, Electronics Manufacturing
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 35.3% |
| Value at Risk 5%th | 53.9% |
| Relative Tail Risk | -7.07% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.99 |
| Alpha | 29.86 |
| CAGR/Max DD | 2.12 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.377 |
| Beta | 1.201 |
| Beta Downside | 1.059 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.72% |
| Mean DD | 5.59% |
| Median DD | 4.68% |
Description: OSIS OSI Systems November 09, 2025
OSI Systems (NASDAQ:OSIS) designs and manufactures electronic systems and components across three business segments-Security, Healthcare, and Optoelectronics & Manufacturing. The Security segment, sold under the Rapiscan and S2 brands, provides baggage, cargo, vehicle and personnel screening equipment plus turnkey services. The Healthcare segment (Spacelabs) supplies patient-monitoring, cardiology and connected-care solutions for hospitals and outpatient settings. The Optoelectronics & Manufacturing segment delivers laser diodes, flexible circuits and LCD displays to aerospace, defense, medical imaging, telecom and industrial customers, while also offering contract electronics manufacturing services.
Key metrics (as of the most recent FY 2024 filing) show total revenue of $1.02 billion, with the Security segment contributing roughly 55 % of sales and posting a 13 % operating margin, while Healthcare grew 8 % YoY on the back of expanding remote-monitoring adoption. The company’s backlog in security screening equipment is estimated at $250 million, reflecting sustained demand from airport modernization programs and heightened cargo-security regulations. Macro-level drivers include rising global defense spending (projected 3.5 % CAGR through 2028) and a post-pandemic surge in elective procedures that fuels demand for Spacelabs’ monitoring devices.
For a deeper, data-driven assessment of OSI Systems’ valuation and risk profile, you may find the analyst tools on ValueRay useful for building a more granular financial model.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (152.3m TTM) > 0 and > 6% of Revenue (6% = 105.2m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 14.50pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 39.10% (prev 36.21%; Δ 2.89pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 151.9m <= Net Income 152.3m (YES >=105%, WARN >=100%) |
| Net Debt (-119.0m) to EBITDA (262.7m) ratio: -0.45 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.87 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (17.5m) change vs 12m ago 2.45% (target <= -2.0% for YES) |
| Gross Margin 33.58% (prev 33.44%; Δ 0.14pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 79.49% (prev 78.06%; Δ 1.43pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.90 (EBITDA TTM 262.7m / Interest Expense TTM 31.9m) >= 6 (WARN >= 3) |
Altman Z'' 4.73
| (A) 0.30 = (Total Current Assets 1.48b - Total Current Liabilities 791.7m) / Total Assets 2.30b |
| (B) 0.42 = Retained Earnings (Balance) 962.8m / Total Assets 2.30b |
| (C) 0.10 = EBIT TTM 220.3m / Avg Total Assets 2.21b |
| (D) 0.70 = Book Value of Equity 946.0m / Total Liabilities 1.35b |
| Total Rating: 4.73 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 69.60
| 1. Piotroski 6.0pt |
| 2. FCF Yield 3.11% |
| 3. FCF Margin 7.60% |
| 4. Debt/Equity 0.01 |
| 5. Debt/Ebitda -0.45 |
| 6. ROIC - WACC (= 0.79)% |
| 7. RoE 16.91% |
| 8. Rev. Trend 72.62% |
| 9. EPS Trend 45.86% |
What is the price of OSIS shares?
Over the past week, the price has changed by +0.43%, over one month by +6.26%, over three months by +10.12% and over the past year by +51.86%.
Is OSIS a buy, sell or hold?
- Strong Buy: 4
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the OSIS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 295 | 10.5% |
| Analysts Target Price | 295 | 10.5% |
| ValueRay Target Price | 383.8 | 43.8% |
OSIS Fundamental Data Overview December 15, 2025
P/E Trailing = 29.3153
P/E Forward = 24.9377
P/S = 2.5116
P/B = 4.6564
P/EG = 2.0759
Beta = 1.347
Revenue TTM = 1.75b USD
EBIT TTM = 220.3m USD
EBITDA TTM = 262.7m USD
Long Term Debt = 436.8m USD (from longTermDebt, last quarter)
Short Term Debt = 5.38m USD (from shortTermDebt, last quarter)
Debt = 5.38m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -119.0m USD (from netDebt column, last quarter)
Enterprise Value = 4.29b USD (4.40b + Debt 5.38m - CCE 124.4m)
Interest Coverage Ratio = 6.90 (Ebit TTM 220.3m / Interest Expense TTM 31.9m)
FCF Yield = 3.11% (FCF TTM 133.3m / Enterprise Value 4.29b)
FCF Margin = 7.60% (FCF TTM 133.3m / Revenue TTM 1.75b)
Net Margin = 8.68% (Net Income TTM 152.3m / Revenue TTM 1.75b)
Gross Margin = 33.58% ((Revenue TTM 1.75b - Cost of Revenue TTM 1.16b) / Revenue TTM)
Gross Margin QoQ = 32.03% (prev 33.32%)
Tobins Q-Ratio = 1.86 (Enterprise Value 4.29b / Total Assets 2.30b)
Interest Expense / Debt = 137.5% (Interest Expense 7.40m / Debt 5.38m)
Taxrate = 19.94% (5.12m / 25.7m)
NOPAT = 176.4m (EBIT 220.3m * (1 - 19.94%))
Current Ratio = 1.87 (Total Current Assets 1.48b / Total Current Liabilities 791.7m)
Debt / Equity = 0.01 (Debt 5.38m / totalStockholderEquity, last quarter 946.0m)
Debt / EBITDA = -0.45 (Net Debt -119.0m / EBITDA 262.7m)
Debt / FCF = -0.89 (Net Debt -119.0m / FCF TTM 133.3m)
Total Stockholder Equity = 900.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.62% (Net Income 152.3m / Total Assets 2.30b)
RoE = 16.91% (Net Income TTM 152.3m / Total Stockholder Equity 900.5m)
RoCE = 16.47% (EBIT 220.3m / Capital Employed (Equity 900.5m + L.T.Debt 436.8m))
RoIC = 11.22% (NOPAT 176.4m / Invested Capital 1.57b)
WACC = 10.43% (E(4.40b)/V(4.41b) * Re(10.44%) + (debt cost/tax rate unavailable))
Discount Rate = 10.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.49%
[DCF Debug] Terminal Value 60.47% ; FCFE base≈133.3m ; Y1≈87.5m ; Y5≈40.0m
Fair Price DCF = 32.85 (DCF Value 557.7m / Shares Outstanding 17.0m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 45.86 | EPS CAGR: 2.81% | SUE: -0.14 | # QB: 0
Revenue Correlation: 72.62 | Revenue CAGR: 9.18% | SUE: 0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.86 | Chg30d=+0.093 | Revisions Net=+5 | Analysts=6
EPS current Year (2026-06-30): EPS=10.42 | Chg30d=+0.139 | Revisions Net=+4 | Growth EPS=+11.3% | Growth Revenue=+7.5%
EPS next Year (2027-06-30): EPS=11.39 | Chg30d=+0.166 | Revisions Net=+5 | Growth EPS=+9.3% | Growth Revenue=+5.5%
Additional Sources for OSIS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle